MCID: BRN039
MIFTS: 43

Bronchial Neoplasm

Categories: Cancer diseases, Respiratory diseases

Aliases & Classifications for Bronchial Neoplasm

MalaCards integrated aliases for Bronchial Neoplasm:

Name: Bronchial Neoplasm 12 15 17
Neoplasm of Bronchus 12
Bronchial Neoplasms 45
Bronchus Neoplasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3906
MeSH 45 D001984
UMLS 74 C0006264

Summaries for Bronchial Neoplasm

MalaCards based summary : Bronchial Neoplasm, also known as neoplasm of bronchus, is related to pulmonary blastoma and small cell cancer of the lung. An important gene associated with Bronchial Neoplasm is MIB1 (Mindbomb E3 Ubiquitin Protein Ligase 1), and among its related pathways/superpathways is Angiogenesis (CST). The drugs Pemetrexed and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include lung, brain and breast, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Bronchial Neoplasm

Diseases related to Bronchial Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 92)
# Related Disease Score Top Affiliating Genes
1 pulmonary blastoma 30.9 NKX2-1 SYP
2 small cell cancer of the lung 30.2 KRT7 NKX2-1 POMC SYP
3 bronchus cancer 11.2
4 pleuropulmonary blastoma type 1 10.5
5 pleuropulmonary blastoma type 2 10.5
6 pleuropulmonary blastoma type 3 10.5
7 lymphatic malformations 10.4 FLT4 PROX1
8 pleuropulmonary blastoma 10.4
9 well-differentiated fetal adenocarcinoma of the lung 10.4
10 hemangioendothelioma 10.4 FLT4 PECAM1
11 solid adenocarcinoma with mucin production 10.4 KRT7 NKX2-1
12 ovarian germ cell teratoma 10.4 KRT7 NKX2-1
13 gangliocytoma 10.4 POMC SYP
14 lung acinar adenocarcinoma 10.4 KRT7 NKX2-1
15 malignant leydig cell tumor 10.4 KRT7 POMC
16 ovarian germ cell cancer 10.4 KRT7 NKX2-1
17 lung cancer 10.3
18 papillary adenoma 10.3 KRT7 NKX2-1
19 pancreatic endocrine carcinoma 10.3 POMC SYP
20 sella turcica neoplasm 10.3 POMC SYP
21 ovary neuroendocrine neoplasm 10.3 KRT7 SYP
22 tuberculum sellae meningioma 10.3 POMC SYP
23 mucinous adenofibroma 10.3 KRT7 SYP
24 olfactory nerve neoplasm 10.3 POMC SYP
25 pericardial tuberculosis 10.3 POMC TBP
26 sensory organ benign neoplasm 10.3 KRT7 SYP
27 papillary serous adenocarcinoma 10.3 KRT7 NKX2-1
28 skin hemangioma 10.3 FLT1 PROX1
29 middle ear adenoma 10.3 KRT7 SYP
30 male reproductive organ benign neoplasm 10.3 POMC SYP
31 gallbladder small cell carcinoma 10.3 KRT7 SYP
32 intestinal perforation 10.3 KRT7 NKX2-1
33 pancreatic serous cystadenoma 10.3 KRT7 SYP
34 seminal vesicle tumor 10.3 KRT7 SYP
35 hobnail hemangioma 10.3 CD34 FLT4
36 medulloepithelioma 10.2 KRT7 SYP
37 glycogen-rich clear cell breast carcinoma 10.2 KRT7 SYP
38 carcinoid tumors, intestinal 10.2 NKX2-1 SYP
39 malignant epithelioid hemangioendothelioma 10.2 CD34 FLT4
40 respiratory system benign neoplasm 10.2 NKX2-1 SYP
41 glomeruloid hemangioma 10.2 CD34 FLT1
42 mucinous bronchioloalveolar adenocarcinoma 10.2 KRT7 NKX2-1
43 thyroid cancer, nonmedullary, 2 10.2 FLT1 NKX2-1 POMC
44 vulvar sarcoma 10.2 CD34 KRT7
45 mucinous ovarian cystadenoma 10.2 KRT7 SYP
46 sex cord-gonadal stromal tumor 10.2 KRT7 POMC SYP
47 small cell carcinoma 10.2 KRT7 NKX2-1 SYP
48 small cell carcinoma of the bladder 10.2 KRT7 NKX2-1 SYP
49 pulmonary sclerosing hemangioma 10.2 KRT7 NKX2-1 SYP
50 sclerosing hemangioma 10.2 KRT7 NKX2-1 SYP

Graphical network of the top 20 diseases related to Bronchial Neoplasm:



Diseases related to Bronchial Neoplasm

Symptoms & Phenotypes for Bronchial Neoplasm

MGI Mouse Phenotypes related to Bronchial Neoplasm:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.76 FLT1 FLT4 MIB1 NKX2-1 PECAM1 POMC
2 homeostasis/metabolism MP:0005376 9.7 CD34 FLT1 FLT4 KRT7 MIB1 NKX2-1
3 normal MP:0002873 9.23 EMP1 FLT1 FLT4 MIB1 NKX2-1 PROX1

Drugs & Therapeutics for Bronchial Neoplasm

Drugs for Bronchial Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 798)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pemetrexed Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 150399-23-8, 137281-23-3 60843 446556
2
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 15663-27-1 2767 441203 84093
3
Docetaxel Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 114977-28-5 148124
4
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33069-62-4 36314
5
Irinotecan Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 100286-90-6, 97682-44-5 60838
6
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 33419-42-0 36462
7
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 95058-81-4 60750
8
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
9
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 41575-94-4 10339178 38904 498142
10
Gefitinib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 184475-35-2 123631
11
Vinblastine Approved Phase 4,Phase 3,Phase 2,Phase 1 865-21-4 241903 13342
12
afatinib Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 850140-72-6, 439081-18-2 10184653
13
Vinorelbine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 71486-22-1 44424639 60780
14
Sunitinib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 557795-19-4, 341031-54-7 5329102
15
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 216974-75-3
16
Pembrolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1374853-91-4
17
Atezolizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1380723-44-3
18
nivolumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 946414-94-4
19
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
20
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
21
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
22
Caffeine Approved Phase 4 58-08-2 2519
23
Modafinil Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 68693-11-8 4236
24
Zoledronic Acid Approved Phase 4,Phase 3,Phase 2 118072-93-8 68740
25
Osimertinib Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 1421373-65-0 71496458
26
Trametinib Approved Phase 4,Phase 2,Phase 1 871700-17-3 11707110
27
Dabrafenib Approved, Investigational Phase 4,Phase 2 1195765-45-7 44462760 44516822
28
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
29
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
30
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
31
Tyrosine Approved, Investigational, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 60-18-4 6057
32
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-70-2 271
33
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
34
Creatine Approved, Investigational, Nutraceutical Phase 4 57-00-1 586
35
Lactitol Investigational Phase 4,Phase 2,Phase 1 585-88-6, 585-86-4 493591
36 Flurbiprofen axetil Investigational Phase 4 91503-79-6
37 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
38 Endostar protein Phase 4,Phase 3,Phase 2,Phase 1
39 Angiogenesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Angiogenesis Modulating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Endostatins Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 71581480
42 Albumin-Bound Paclitaxel Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
44 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 topoisomerase I inhibitors Phase 4,Phase 3,Phase 2,Phase 1
46 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Folate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 4537)
# Name Status NCT ID Phase Drugs
1 Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma Unknown status NCT02103257 Phase 4 Sequential Icotinib Plus Chemotherapy;Icotinib
2 Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases Unknown status NCT01926171 Phase 4 Icotinib plus WBRT
3 Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma Unknown status NCT01665417 Phase 4 Experimental;Chemotherapy;Chemotherapy
4 First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients Unknown status NCT01646450 Phase 4 Icotinib
5 Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) Unknown status NCT00813332 Phase 4 Endostar(rh recombinant endostatin) plus Docetaxel;Placebo plus Docetaxel
6 Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research Unknown status NCT02513355 Phase 4 Changchun marina;cisplatin;Taxol;parapl
7 Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer Unknown status NCT02348450 Phase 4 Irinotecan;Etoposide;Cisplatin
8 Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer Unknown status NCT02195453 Phase 4 Yangzhengxiaoji Capsule;Placebo Capsule
9 Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC Unknown status NCT02194556 Phase 4 Sequential and maintenance icotinib;Maintenance icotinib
10 Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer Unknown status NCT02031601 Phase 4 Erlotinib;Gefitinib;Icotinib;Docetaxel;Pemetrexed;Platinum (cisplatin or carboplatin);Erlotinib;Gefitinib;Icotinib
11 Maintenance Gemcitabine in the Chinese Advanced Lung Cancer Unknown status NCT01336192 Phase 4 Gemcitabine;Best supportive care
12 Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) Unknown status NCT01211002 Phase 4 radiotherapy / EP combined with recombinant human endostatin
13 A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) Unknown status NCT01028729 Phase 4 Endostar;Gemcitabine-Cisplatin chemotherapy
14 The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Completed NCT03384511 Phase 4 Apatinib
15 Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Completed NCT03092986 Phase 4 Paclitaxel;Carboplatin;Cisplatin;Vinblastine Sulfate
16 Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Completed NCT02514174 Phase 4 Afatinib
17 Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation Completed NCT02208843 Phase 4 Afatinib
18 Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population Completed NCT02000531 Phase 4 Erlotinib;Chemotherapy
19 Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC Completed NCT01848613 Phase 4 Vinorelbine
20 A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations Completed NCT01609543 Phase 4 erlotinib [Tarceva]
21 Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose Completed NCT01465243 Phase 4 Icotinib
22 Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients Completed NCT01402089 Phase 4 Sunitinib;Erlotinib;Midazolam;Caffeine
23 Modafinil for the Treatment of Fatigue in Lung Cancer V9.0 Completed NCT00829322 Phase 4 Modafinil;Placebo
24 Oncoxin® and Quality of Life in Cancer Patients Completed NCT03550482 Phase 4
25 Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC Completed NCT02497118 Phase 4 Endostatin;Vinorelbine;Cisplatin
26 Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab Completed NCT02316327 Phase 4 gemcitabine, cisplatin and bevacizumab
27 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Completed NCT02151149 Phase 4 nab-paclitaxel;Carboplatin
28 Pemetrexed Followed by Docetaxel or in Reverse Sequence Completed NCT01442909 Phase 4 Docetaxel and pemetrexed
29 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations Completed NCT01287754 Phase 4 erlotinib [Tarceva]
30 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression Completed NCT01230710 Phase 4 Erlotinib
31 A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer Completed NCT01196078 Phase 4 erlotinib [Tarceva];vinorelbine
32 A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Completed NCT01066884 Phase 4 erlotinib [Tarceva]
33 A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients Completed NCT01020786 Phase 4 Pemetrexed;Carboplatin
34 A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa Completed NCT01000740 Phase 4
35 An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Completed NCT00949910 Phase 4 Erlotinib
36 Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer Completed NCT00883675 Phase 4 Docetaxel-Carboplatin
37 Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) Completed NCT00770588 Phase 4 Gefitinib;Placebo
38 Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates Completed NCT00765687 Phase 4 bisphosphates
39 Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis Completed NCT00762346 Phase 4 zometa
40 Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) Completed NCT00686322 Phase 4 Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy)
41 SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients Completed NCT00608868 Phase 4 Gefitinib
42 A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. Completed NCT00451906 Phase 4 Platinum-based chemotherapy;Bevacizumab [Avastin]
43 Chemotherapy for Patients With Non-Small Cell Lung Cancer Completed NCT00380718 Phase 4 pemetrexed
44 Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy Completed NCT00115206 Phase 4 Neulasta® (pegfilgrastim)
45 Non-small Cell Lung Cancer Registry Completed NCT00099541 Phase 4 zoledronic acid
46 Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) Recruiting NCT03715205 Phase 4 Pembrolizumab
47 Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC Recruiting NCT03712969 Phase 4 Shenlingcao Oral Liquid
48 Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies Recruiting NCT03607149 Phase 4 Pemetrexed
49 Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. Recruiting NCT03460678 Phase 4 Pemetrexed;Erlotinib
50 A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Recruiting NCT03285763 Phase 4 Atezolizumab

Search NIH Clinical Center for Bronchial Neoplasm

Cochrane evidence based reviews: bronchial neoplasms

Genetic Tests for Bronchial Neoplasm

Anatomical Context for Bronchial Neoplasm

MalaCards organs/tissues related to Bronchial Neoplasm:

42
Lung, Brain, Breast, Testes, T Cells, Bone, Prostate

Publications for Bronchial Neoplasm

Articles related to Bronchial Neoplasm:

(show all 16)
# Title Authors Year
1
Association of esophageal achalasia and pulmonary actinomycosis infection simulating bronchial neoplasm. ( 10384207 )
1999
2
Papillary variant of low-grade mucoepidermoid carcinoma--an unusual bronchial neoplasm. A light microscopic, ultrastructural, and immunohistochemical study. ( 8135181 )
1994
3
The role of the fibreoptic bronchoscope in the diagnosis of bronchial neoplasm. ( 3688809 )
1987
4
Resection of bronchial neoplasm in the elderly. ( 3804680 )
1986
5
Bronchoscopy guided simulation of a bronchial neoplasm. ( 4030445 )
1985
6
Pulmonary actinomycosis simulating a bronchial neoplasm. ( 6875291 )
1983
7
Bronchial neoplasm with eosinophilia. ( 7306452 )
1981
8
Adenoid cystic carcinoma of the cervix presenting as a primary bronchial neoplasm. ( 4372888 )
1974
9
The bronchocele in bronchial neoplasm. ( 5417251 )
1970
10
Cushing's syndrome associated with a "corticotrophin"-producing bronchial neoplasm neoplasm (results of corticotrophin assays and of pituitary-adrenal function tests). ( 4293813 )
1967
11
Bronchial neoplasm with endocrine, metabolic, and neurological manifestations. Report of a case. ( 4293855 )
1967
12
Pemphigoid, bronchial neoplasm and radiotherapy. ( 6066575 )
1967
13
OPHTHALMOPLEGIA OF MYASTHENIA AND BRONCHIAL NEOPLASM. ( 14048792 )
1963
14
The role of radiation therapy in the treatment of primary bronchial neoplasm. ( 13600264 )
1958
15
BRONCHIAL neoplasm with myasthenia. ( 13118739 )
1954
16
Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine. ( 13110148 )
1953

Variations for Bronchial Neoplasm

Expression for Bronchial Neoplasm

Search GEO for disease gene expression data for Bronchial Neoplasm.

Pathways for Bronchial Neoplasm

Pathways related to Bronchial Neoplasm according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.87 FLT1 FLT4 PECAM1 PROX1

GO Terms for Bronchial Neoplasm

Biological processes related to Bronchial Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 vascular endothelial growth factor signaling pathway GO:0038084 9.26 FLT1 FLT4
2 lymph vessel development GO:0001945 9.16 FLT4 PROX1
3 lymphangiogenesis GO:0001946 8.96 FLT4 PROX1
4 glomerular endothelium development GO:0072011 8.62 CD34 PECAM1

Molecular functions related to Bronchial Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nuclear receptor binding GO:0016922 8.96 BAZ2A PROX1
2 vascular endothelial growth factor-activated receptor activity GO:0005021 8.62 FLT1 FLT4

Sources for Bronchial Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....